openPR Logo
Press release

Inhalation Anesthesia Market Size to hit $1.5 billion by 2026, Top Prominent Players: AbbVie Inc., Baxter International Inc., Fresenius SE & Co. KGaA., Halocarbon Products Corporation

04-01-2020 12:33 PM CET | Health & Medicine

Press release from: Allied Market Research

Inhalation Anesthesia Market

Inhalation Anesthesia Market

Inhalation anesthetics is mainly used for tracheal intubation for patients with upper airway obstruction. Inhalation anesthesia evades the complications associated with injectable agents, as the agents have problems of dose calculation, and disparities in response do not arise. Further, these anesthetics offers the surgeons with numerous advantages. For instance, the respiratory route of administration enables fast and convenient adjustment of anesthetic depth.

The global inhalation anesthesia market size is expected to reach $1,549 million by 2026, registering a CAGR of 4.2% from 2019 to 2026, in terms of value.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6445

Surge in the cases of emergency incidences and road accidents, rise in prevalence of several disorders such as cancer, respiratory diseases, and gastrointestinal, and surge in number of surgical procedures are the major factors driving the inhalation anesthesia market. However, risks associated with certain therapeutic and diagnostic devices for neonate and environmental concerns regarding vigorous usage of inhalation anesthesia restrain the growth of the inhalation anesthesia market. On the contrary, significant rise in geriatric population across the globe and increase in healthcare expenditures in developing economies are anticipated to provide lucrative growth opportunities for the market in the future.

By product, the sevoflurane segment accounted for majority of the market share in 2018 and is expected to exhibit a prominent growth rate in the future. This is attributed to several advantages offered by it, such as favorable blood gas solubility coefficient and pleasant odor.

By application, the maintenance segment dominated the inhalation anesthesia market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the increased use of inhalation anesthesia for maintenance of general anesthesia as they enable a more specific control of the anesthetic state at a low cost.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6445

Region wise, North America accounted for majority of the global inhalation anesthesia market share in 2018, and is anticipated remain dominant during the forecast period. The increase in prevalence of different types of cancers, neurological, and respiratory diseases such as Parkinson's, Alzheimer's, glaucoma, cataract, and AMD, make way for growth opportunities for major manufacturers for anesthetics in the region. However, Asia-Pacific is anticipated to grow at the fastest rate during the forecast period, owing to increased disposable income in developing economies such as India and China.

The Major Key Players Are:

AbbVie Inc., Baxter International Inc., Fresenius SE & Co. KGaA., Halocarbon Products Corporation, Hikma Pharmaceuticals PLC., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd, Novartis AG, Piramal Enterprises Ltd, and Troikaa Pharmaceuticals Ltd are provided in this report.

Key Findings of the Study:

o By product, the sevoflurane segment accounted for the highest market share of 58% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
o By region, North America was the major shareholder and accounted for the highest share of 46% in 2018.
o By application, maintenance segment is expected to grow at a CAGR of 4.3% during the forecast period.
o By end user, the hospital segment dominated the market in 2018 and is anticipated to maintain its dominance during the forecast period.

Access Full Report @ https://www.alliedmarketresearch.com/inhalation-anesthesia-market-A06080

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inhalation Anesthesia Market Size to hit $1.5 billion by 2026, Top Prominent Players: AbbVie Inc., Baxter International Inc., Fresenius SE & Co. KGaA., Halocarbon Products Corporation here

News-ID: 1994472 • Views: 153

More Releases from Allied Market Research

Drug Screening Laboratory Services Market Share Size, Statistics, Demand, Revenu …
Drug Screening Laboratory Services Market by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027 by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil
Orthopedic Devices Market Global Growth, Current Scenario Technology Trends, Com …
Rise in geriatric population and increase in chronic diseases related to orthopedics such as osteoarthritis, traumatic fractures, osteopenia, and others are play a major role in the growth of the orthopedic device market. In addition, various growth opportunities such as surge in healthcare infrastructure, increase in affordability, and rise in awareness related to orthopedic conditions in emerging economies are expected to boost the market growth in the coming years. Download Free
Neurosurgery Devices Market: Global Trends, Segmentation and Opportunities Forec …
Neurosurgery devicesare devices that help in prevention, treatment, and diagnosis of conditions and disorders associated with nervous system mainly the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system. The neurological conditions include dementia, headache disorders, neuro-infections, and multiple sclerosis, traumatic brain injuries, pain associated with neurological disorders, neurological disorders associated with malnutrition, stroke, epilepsy and Parkinson’s disease.These disorders are fatal and cannot be cured by therapeutics. Some of the
COVID-19 Impact on Nerve Repair and Regeneration Market Global Industry Size, Sh …
Global Nerve Repair and Regeneration Market are expected to reach $13,938 million by 2023, growing at a CAGR of 13.0 % during the forecast period, 2019-2023. The factors propelling the nerve repair and regeneration market are rise in geriatric population, growing prevalence of neurological and epidemic disorders, and introduction of novel and innovative products for nerve repair and regeneration. However, stringent regulatory requirements for product approvals, lack of skilled professionals, and

All 5 Releases


More Releases for Inhalation

Inhalation Anesthesia Market Size, Share | Industry Report 2026
The Inhalation Anesthesia Market was valued at $1.6billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $2.1 billion. Inhalation Anesthesia refers to the delivery of vapors or gases to the respiratory system to produce anesthesia. It is accepted that ether, chloroform, and nitrox oxide. Inhalation anesthesia is used for that sevoflurane, desflurane, isoflurane, halothane, and nitrous
Inhalation Anesthetics Market to Record Sturdy Growth by 2025
In medical practice, anesthesia is a state of body, induced by drugs to suppress sensations which are called as anesthetics. Anesthetic agents act on the central nervous system altering the motor function of neurons. Anesthesia is employed during major and minor surgeries to ease the procedure for surgeon and patient. Anesthetic agents can be administered intravenously, subcutaneously, orally, or by inhalation. Various inhalation anesthetics have been in use for a
Inhalation Anesthesia Market trends research and projections for 2017-2024
The surging prevalence of heart & respiratory ailments & surgical procedures, incidentally, is a major driving force for inhalation anesthesia market. In recent times, the occurrence rate of road accidents has soared to an indefinite extent, necessitating the requirement of critical care during surgical procedures, and by extension, leading to the generation of a profitable avenue for inhalation anesthesia industry. According to the ASIRT (Association for Safe International Road Travel),
Global Inhalation and Nasal Spray Generic Drugs Market – Industry Analysis
The global market for inhalation and nasal spray generic drugs features a largely fragmented, not to mention intensely competitive owing to pricing pressures, vendor landscape, with the top four companies accounting for a nearly 46% of the overall market in 2014, observes Transparency Market Research (TMR) in a recent report. These leading companies, namely Sandoz International GmbH, Mylan N.V., Allergan PLC, and Teva Pharmaceutical Industries Ltd., are focusing on growth
Inhalation Systems Market - Detailed Qualitative Analysis upto 2019
The era of development is leading to a hazardous increase in environmental pollution, which is giving birth to a number of chronic respiratory diseases such as asthma and COPD and is resulting in both physical and psychological suffering for the patients. The global market for inhalation systems is growing rapidly because of increasing respiratory problems and is expected to have a high growth rate during the period from 2012 to
Inhalation Drug Delivery Devices Market
Boston, MA ReportsWorldwide has announced the addition of a new report title Inhalation Drug Delivery Devices Market to its growing collection of premium market research reports. The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million. The combined market for inhalation drug delivery devices totaled nearly $11.7bn in 2016, and